Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07247227 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Real-world First-line Sugemalimab-Chemotherapy in Advanced NSCLC

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This single-arm, multi-center study is to evaluate Sugemalimab plus platinum-based chemotherapy as first-line therapy for patients with locally advanced and metastatic NSCLC in a real-world setting.
Trial Details
NCT Number NCT07247227
Lead Sponsor Peking Union Medical College
Conditions
(from sponsor)		 NSCLC
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov